A Focused Pipeline Built Around the Body's First Response

Ness Therapeutics Inc. is advancing a focused pipeline of host-directed programs designed for respiratory protection, outbreak preparedness, and broader platform expansion.
N001 is the lead program. Additional applications are being evaluated where the underlying biology supports them.

Explore Investment OpportunitiesDiscover N001
Illustration of glowing organic cells with multiple tentacle-like extensions on a light background.
Clear nasal spray bottle labeled N001 on a reflective white surface with laboratory glassware in the background.
Illustration of a yellow immune cell engulfing a blue virus particle.
PIPELINE

Ness Therapeutics Inc. Active Programs

A focused set of host-directed programs advancing across respiratory, viral, and oncology settings.

Program & Indication
Route
Preclinical
IND/CTA-Enabling
Clinical
N001 - Respiratory virus prophylaxis
Intranasal
Intranasal
A blue icon used to show progress in product pipeline.
N003 - Non-respiratory virus prophylaxis
Route TBD
TBD
A blue icon used to show progress in product pipeline.
N004 - Enterovirus prophylaxis
Route TBD
TBD
A blue icon used to show progress in product pipeline.
N007 - Oncology
Intranasal
Intranasal
A blue icon used to show progress in product pipeline.
Explore Investment Opportunities
Discover Our Science

A Pipeline Led by N001

N001 is Ness Therapeutics Inc.'s first host-directed, virus-agnostic intranasal prophylactic. N001 is advancing toward first-in-human readiness as the foundation of a broader platform built around early immune intervention.

Investment OpportunitiesLearn More About N001
PLATFORM EXPANSION

Expanding Where the Biology Leads

Ness Therapeutic Inc. is selectively expanding its platform into non-respiratory viral protection and oncology, pursuing applications where the host-directed mechanism and underlying biology support translational potential.

Illustration of various glowing yellow virus or cell-like structures with spiky and round shapes against a light background.
N003

Non-Respiratory Viral Protection

Exploring host-directed protection beyond the respiratory tract.

Close-up view of colorful virus particles with textured surfaces in yellow, blue, and beige hues on a light background.
N004

Enterovirus Protection

Evaluating targeted approaches for enterovirus infections.

Glowing golden user icon with a shield featuring a medical cross symbol in front.
N007

Oncology
Immune Activation

Early-stage exploration of host-directed immune activation in oncology.

Program and Company Updates

Sign up to receive updates on N001's development milestones, regulatory progress, and key program announcements as Ness Therapeutics Inc. advances toward clinical readiness.

By entering your email address, you agree to receive emails from Ness Therapeutics Inc. You may unsubscribe at any time.
Thank you for your interest in Ness Therapeutics.
Something went wrong. Please try again.